ProCE Banner Activity

Expert Answers to Questions on RSV Vaccination in Adults

Clinical Thought

Experts address frequently asked questions on RSV vaccination, including vaccine administration, key populations at high-risk for severe disease, and considerations for vaccine implementation using clinical shared decision-making.

Released: May 15, 2024

Expiration: May 14, 2025

Share

Faculty

Angela Branche

Angela Branche, MD, FIDSA

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Rochester
Rochester, New York

Jewel Mullen

Jewel Mullen, MD, MPH, MPA, FACP

Associate Dean for Health Equity
Associate Professor of Population Health and Internal Medicine
University of Texas at Austin Dell Medical School
Austin, Texas

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This educational activity is supported by an educational grant from GlaxoSmithKline.

GlaxoSmithKline

Faculty Disclosure

Primary Author

Angela Branche, MD, FIDSA

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Rochester
Rochester, New York

Angela Branche, MD, FIDSA: consultant/advisor/speaker: GlaxoSmithKline, Moderna, Novavax; researcher: CyanVac, Moderna, Pfizer, Vaccitech.

Jewel Mullen, MD, MPH, MPA, FACP

Associate Dean for Health Equity
Associate Professor of Population Health and Internal Medicine
University of Texas at Austin Dell Medical School
Austin, Texas

Jewel Mullen, MD, MPH, MPA, FACP, has no relevant financial relationships to disclose.